Why you may not have to pay the tax on Obamacare? Avik Roy joins Jim Blasingame to explain that while the IRS is charged with collecting the penalty tax on Obamacare if you don't have insurance, it can't force you to pay it.
Why your Health Savings Account is in danger with Obamacare. Avik Roy joins Jim Blasingame to explain how Obamacare is designed to end the effectiveness of health savings accounts (HSA).
Be careful who you listen to when getting news about Obamacare. Avik Roy joins Jim Blasingame to reveal some of the bad reporting and misinformation about Obamacare that is being supported by the mainstream media.
Which plan will do more harm to those currently on Medicare? Avik Roy joins Jim Blasingame to compare the impact on Medicare for existing seniors by Obamacare and the Romney-Ryan plans.
Can private insurers help save Medicare? Avik Roy joins Jim Blasingame to report on how private insurers could contribute to saving Medicare by taking over the management of the program, but not the underwriting.
Will Obamacare create millions of new public sector union members? Avik Roy joins Jim Blasingame to report on how Obamacare could create millions of new public sector union members and billions in dues for unions like SEIU.
What is the "Slacker Mandate?" Avik Roy joins Jim Blasingame to explain the ObamaCare's "Slacker Mandate" and how it will be impacted with the Supreme Court's decision on this law.
What are the variable kinds of rulings that the Supreme Court could make on ObamaCare? Avik Roy joins Jim Blasingame to report on the different options for how the Supreme Court could rule as they consider the constitutionality of ObamaCare.
The cost of taking a new drug to market is over ten times more today than in 1975. Avik Roy joins Jim Blasingame to report on the cost of complying with current FDA regulations is making new drug development prohibitive.
Can FDA approval for new drugs become less onerous? Avik Roy joins Jim Blasingame to report on the high costs of FDA-required clinical trials and the advantages of an accelerated trial program.
